Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/09/2012CA2805075A1 Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
02/09/2012CA2804878A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012CA2804377A1 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
02/09/2012CA2804077A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012CA2803388A1 Methods of inhibition of protein fucosylation in vivo using fucose analogs
02/09/2012CA2802935A1 Combinations comprising atypical antipsychotics and taar1 agonists
02/09/2012CA2802272A1 Prediction of hcv viral kinetics in interferon-free treatment
02/08/2012EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria
02/08/2012EP2415871A1 Polyion complex of double-stranded ribonucleic acid
02/08/2012EP2415870A1 Rnai molecule for thymidylate synthase and use thereof
02/08/2012EP2415869A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof
02/08/2012EP2415776A1 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
02/08/2012EP2415775A1 Agent for inhibiting thickening of peritoneal membrane
02/08/2012EP2415774A1 Crystals of prasugrel hydrobromate
02/08/2012EP2415771A1 Indolizine derivative and use thereof for medical purposes
02/08/2012EP2415770A1 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof
02/08/2012EP2415768A1 Tricyclic condensed heterocyclic compound, method for producing same, and use thereof
02/08/2012EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors
02/08/2012EP2415765A1 Pyrimidine compound
02/08/2012EP2415764A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
02/08/2012EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma
02/08/2012EP2415760A2 CCR-9 antagonists
02/08/2012EP2415759A1 CETP inhibitors
02/08/2012EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
02/08/2012EP2415755A1 Plasminogen activator inhibitor-1 inhibitor
02/08/2012EP2415749A1 New salvianolic acid compound l, preparation method and use thereof
02/08/2012EP2415748A1 Novel anti-inflammatory compounds
02/08/2012EP2415486A2 Conjugates and compositions for cellular delivery
02/08/2012EP2415484A1 Sustained local anesthetic composition containing SAIB
02/08/2012EP2415481A2 Immunostimulatory viral RNA oligonucleotides
02/08/2012EP2415475A2 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
02/08/2012EP2415474A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
02/08/2012EP2415473A1 Oral Care Compositions Containing Combinations of Anti-Bacterial and Host-Response Modulating Agents
02/08/2012EP2415472A1 Solid pharmaceutical composition containing amorphous body of solifenacin
02/08/2012EP2415471A1 Use of sigma ligands in opioid-induced hyperalgesia
02/08/2012EP2415470A1 Liposome composition
02/08/2012EP2415469A1 Anti-Resorptive and Bone Building Dietary Supplements and Methods of Use
02/08/2012EP2415468A1 Composition for alleviating ultraviolet radiation-induced damage
02/08/2012EP2415467A1 Production method for ubiquinone powder for use in preparations and product thereof
02/08/2012EP2415466A1 Orally disintegrating coated tablet
02/08/2012EP2415465A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin
02/08/2012EP2415464A1 Method for producing liposome composition
02/08/2012EP2415462A1 Improved pharmaceutical compositions for poorly soluble drugs
02/08/2012EP2415460A1 Formulations of pregabalin for oral administration
02/08/2012EP2415453A1 Skin-whitening agent and cosmetic method for whitening skin
02/08/2012EP2415360A2 Use of DPA(n-6) oils in infant formula
02/08/2012EP2414830A2 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
02/08/2012EP2414549A2 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
02/08/2012EP2414521A2 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders
02/08/2012EP2414518A2 Anti viral therapy
02/08/2012EP2414377A1 Novel derivatives of steroidalý3,2-c¨pyrazole compounds with glucocorticoid activity
02/08/2012EP2414376A1 Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
02/08/2012EP2414375A1 Novel amide derivatives of steroidalý3,2-c¨pyrazole compounds with glucocorticoid activity
02/08/2012EP2414373A1 Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
02/08/2012EP2414372A1 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
02/08/2012EP2414369A1 Imidazo [2, 1-b][ 1, 3, 4]thiadiazole derivatives
02/08/2012EP2414366A1 Spiro derivatives for the modulation of stearoyl-coa desaturase
02/08/2012EP2414365A1 SUBSTITUTED [1,2,4¨TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
02/08/2012EP2414364A1 SUBSTITUTED Ý1,2,4¨TRIAZOLOÝ1,5-a¨PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
02/08/2012EP2414363A1 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d]pyrimidin-4-one derivatives and their use as pde9a modulators
02/08/2012EP2414362A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
02/08/2012EP2414361A1 Substituted heterocyclic compounds
02/08/2012EP2414360A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
02/08/2012EP2414359A1 Peri-fused pyrazolo-pyrimidine compounds
02/08/2012EP2414358A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
02/08/2012EP2414357A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
02/08/2012EP2414356A2 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
02/08/2012EP2414354A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
02/08/2012EP2414352A1 Hepatitis c virus inhibitors
02/08/2012EP2414351A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
02/08/2012EP2414350A1 Hepatitis c virus inhibitors
02/08/2012EP2414349A1 3-ý1,4¨oxazepane-4-pyrimidone derivatives
02/08/2012EP2414348A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
02/08/2012EP2414347A1 P38map kinase inhibitor
02/08/2012EP2414346A1 Autotaxin inhibitors
02/08/2012EP2414344A1 Substituted indolo-pyridinone compounds
02/08/2012EP2414342A1 Oxadiazole derivatives
02/08/2012EP2414341A2 Oxadiazole derivatives
02/08/2012EP2414340A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
02/08/2012EP2414338A1 Salts and hydrates of 4-[(3-chlor-4-fluoro-phenyl)amino]-6-(cis-4-{n-[(morph-1-olino-4-yl)carbonyl]-n-methyl-amino}-cyclohexane-1-yloxy)-7-methoxy-quinazoline, their use as drugs and their production
02/08/2012EP2414336A1 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
02/08/2012EP2414335A2 A process for the purification of eslicarbazepine acetate
02/08/2012EP2414334A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/08/2012EP2414332A1 Acrylamide compounds and the use thereof
02/08/2012EP2414331A1 5-ht receptor modulating compounds
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012EP2414328A2 Dihydroorotate dehydrogenase inhibitors
02/08/2012EP2414327A1 Heterocyclic compounds as autotaxin inhibitors
02/08/2012EP2414323A1 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
02/08/2012EP2414320A1 A process for dimethylation of active methylene groups
02/08/2012EP2413970A2 New therapeutic approaches for treating neuroinflammatory conditions
02/08/2012EP2413968A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
02/08/2012EP2413965A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
02/08/2012EP2413944A1 A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
02/08/2012EP2413942A1 Use of ribose in first response to acute myocardial infarction
02/08/2012EP2413941A1 Renin inhibitors
02/08/2012EP2413940A1 Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia
02/08/2012EP2413939A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
02/08/2012EP2413938A2 Kinase protein binding inhibitors
02/08/2012EP2413937A1 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
1 ... 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 ... 7860